Codexis (CDXS) Non Operating Income (2011 - 2026)
Codexis (CDXS) recorded quarterly Non Operating Income of -$1.3 million in Q1 2026, up 19.17% quarter-over-quarter from -$1.6 million in Q4 2025, and down 36.94% on a YoY basis from -$2.0 million in Q1 2025.
Codexis (CDXS) Non Operating Income (2011 - 2026) Analysis & Trends
Codexis' Non Operating Income history runs 16 years deep, the most recent figure standing at -$1.3 million for Q1 2026.
- In Q1 2026, Non Operating Income fell 36.94% year-over-year to -$1.3 million; the TTM figure through Mar 2026 stood at -$5.2 million (up 52.3% YoY), while the FY2025 annual figure was -$4.8 million, up 53.69% from the prior year.
- Non Operating Income was -$1.3 million for Q1 2026 at Codexis, up from -$1.6 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $216000.0 in Q3 2022 to a low of -$8.3 million in Q4 2023.
- Historically, Non Operating Income has averaged -$1.7 million across 5 years, with a median of -$984000.0 in 2025.
- The sharpest annual moves came in 2022 and 2023: Non Operating Income surged 96.59% in 2022, then slumped 31992.31% in 2023.
- A 5-year view of Non Operating Income shows it stood at -$26000.0 in 2022, then plunged by 31992.31% to -$8.3 million in 2023, then jumped by 52.4% to -$4.0 million in 2024, then jumped by 59.82% to -$1.6 million in 2025, then gained by 19.17% to -$1.3 million in 2026.
- The last three Non Operating Income figures came in at -$1.3 million (Q1 2026), -$1.6 million (Q4 2025), and -$1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 444,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 9.35 Mn |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn | -1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.29 Mn |
| Dec 31, 2025 | -1.60 Mn |
| Sep 30, 2025 | -1.29 Mn |
| Jun 30, 2025 | -984,000.00 |
| Mar 31, 2025 | -942,000.00 |
| Dec 31, 2024 | -3.97 Mn |
| Sep 30, 2024 | -4.92 Mn |
| Jun 30, 2024 | -985,000.00 |
| Mar 31, 2024 | -516,000.00 |
| Dec 31, 2023 | -8.34 Mn |
| Sep 30, 2023 | -3.90 Mn |
| Jun 30, 2023 | -9,000.00 |
| Mar 31, 2023 | -25,000.00 |
| Dec 31, 2022 | -26,000.00 |
| Sep 30, 2022 | 216,000.00 |
| Jun 30, 2022 | -63,000.00 |
| Mar 31, 2022 | -3,000.00 |
| Dec 31, 2021 | 228,000.00 |
| Sep 30, 2021 | 983,000.00 |
| Jun 30, 2021 | 23,000.00 |